目的:观察用放血疗法治疗原发性血色病的治疗效果。方法:对确诊的11例原发性血色病患者进行放血治疗,并在放血治疗前后检测患者的丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、血糖(BS)、血清铁(Fe)、血清铁蛋白(FER)水平,同时检测14例对照者的上述指标。结果:治疗前的ALT、AST和治疗前后的Fe、FER明显高于对照组,差异有统计学意义(P<0.01);治疗后的ALT、AST、Fe和FER明显低于治疗前水平,差异有统计学意义(P<0.01)。结论:放血疗法可显著降低原发性血色病患者体内的含铁量,改善患者的肝功能。 Objective: To observe the therapeutic effect of bloodletting therapy on primary hemochromatosis. Methods: Eleven patients with primary hemochromatosis were treated with exsanguination and ALT, AST and BS were measured before and after blood-letting treatment. , Serum iron (Fe) and serum ferritin (FER) levels were measured. The above indexes of 14 control subjects were also detected. Results: Before treatment, ALT, AST and Fe and FER before and after treatment were significantly higher than those in the control group (P <0.01); ALT, AST, Fe and FER after treatment were significantly lower than those before treatment There was statistical significance (P <0.01). Conclusion: Bloodletting therapy can significantly reduce iron content in patients with primary hemochromatosis and improve liver function in patients.